CIK 0001831828
- Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812744449
- Phone
- +1 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-18 | ENRIGHT PATRICK G Director | Purchase | +909,090 | $11.00 | $10.0M | 3,096,594 |
| 2021-05-18 | ENRIGHT PATRICK G Director | Conversion · Series C Preferred Stock | −2,187,504 | 0 | ||
| 2021-05-18 | Cheng Andrew Director | Conversion | +17,488 | 17,488 | ||
| 2021-05-18 | Cheng Andrew Director | Conversion · Series C Preferred Stock | −17,488 | 0 | ||
| 2021-05-18 | EMSTER KURT VON Director | Conversion | +2,187,504 | 2,187,504 | ||
| 2021-05-18 | EMSTER KURT VON Director | Purchase | +772,727 | $11.00 | $8.5M | 2,960,231 |
| 2021-05-18 | EMSTER KURT VON Director | Conversion · Series C Preferred Stock | −2,187,504 | 0 | ||
| 2021-05-18 | Abingworth LLP 10% owner | Conversion | +2,187,504 | 2,187,504 | ||
| 2021-05-18 | Abingworth LLP 10% owner | Purchase | +772,727 | $11.00 | $8.5M | 2,960,231 |
| 2021-05-17 | EMSTER KURT VON Director | Purchase | +17,828 | $12.04 | $215K | 17,828 |
| 2021-05-13 | Abingworth LLP 10% owner | Grant or award · Stock Option (right to buy) | +9,925 | 9,925 | ||
| 2021-05-13 | Morrison Scott W Director | Grant or award · Stock Option (right to buy) | +9,925 | 9,925 | ||
| 2021-05-13 | Katabi Maha Director | Grant or award · Stock Option (right to buy) | +9,925 | 9,925 | ||
| 2021-05-13 | SEIDENBERG BETH C Director | Grant or award · Stock Option (right to buy) | +9,925 | 9,925 | ||
| 2021-05-13 | ENRIGHT PATRICK G Director | Grant or award · Stock Option (right to buy) | +9,925 | 9,925 | ||
| 2021-05-13 | Cheng Andrew Director | Grant or award · Stock Option (right to buy) | +9,925 | 9,925 | ||
| 2021-05-13 | EMSTER KURT VON Director | Grant or award · Stock Option (right to buy) | +9,925 | 9,925 | ||
| 2021-05-13 | Lin Celia Chief Medical Officer | Grant or award · Stock Option (right to buy) | +16,916 | 16,916 | ||
| 2021-05-13 | Curley Joanne Chief Development Officer | Grant or award · Stock Option (right to buy) | +108,217 | 108,217 | ||
| 2021-05-13 | Young Joseph R SVP, Finance, Chief Acct Offcr | Grant or award · Stock Option (right to buy) | +13,722 | 13,722 |
Page 29 of 30 · 581 trades